Literature DB >> 8986947

Hepatitis C virus genotypes in French haemophiliacs: kinetics and reappraisal of mixed infections.

R Tuveri1, C Rothschild, S Pol, D Reijasse, T Persico, C Gazengel, C Bréchot, V Thiers.   

Abstract

The distribution and kinetics of hepatitis C virus (HCV) genotypes and the prevalence of mixed infections were studied in a group of 45 French patients with haemophilia A or B or von Willebrand's disease, 21 of them being anti-human immunodeficiency virus (HIV) positive; genotyping was carried out by three methods based on the core, 5' untranslated region (5'UTR), and the detection of type-specific NS4 antibodies. Genotyping of the 5'UTR revealed genotypes 1a (n = 10), 1b (n = 13), 2a (n = 3), 2b (n = 4), 2NC (n = 3), 3a (n = 10), and two mixed infections (1a + 1b and 3a + 2). Five of 33 patients showed a change from one HCV genotype to another. The core genotyping assay showed 8 of 45 mixed infections: 6/8 1a + 1b and 2/8 3a + 2. Sequencing of core polymerase chain reaction (PCR) products showed that mixed infection 1a + 1b could be explained by nonspecific annealing of the 1b primer to type 1a sequence. By designing new primers whose sequence was more specific to HCV types 1a and 1b, we could confirm 1a + 1b mixed infection in only one of six cases. Serotyping assay showed for 17 of 21 anti-HIV negative patients a concordance with the 5'UTR genotype; however, only 6 of 19 anti-HIV positive patients showed detectable serological reactivity. In summary, we have observed a similar HCV genotype distribution between our haemophilic group and the French anti-HCV positive patients. The study demonstrates the difficulties of assessing with the presently available genotyping and serotyping assays the real prevalence of mixed infections in multiply transfused patients.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8986947     DOI: 10.1002/(sici)1096-9071(199701)51:1<36::aid-jmv6>3.0.co;2-t

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  11 in total

1.  Multitypic hepatitis C virus infection identified by real-time nucleotide sequencing of minority genotypes.

Authors:  Andrew J Buckton; Siew-Lin Ngui; Catherine Arnold; Katie Boast; Joanne Kovacs; Paul E Klapper; Bharat Patel; Imad Ibrahim; Savita Rangarajan; Mary E Ramsay; Chong-Gee Teo
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

2.  Multiplex real-time reverse transcription-PCR assay for determination of hepatitis C virus genotypes.

Authors:  Linda Cook; KaWing Sullivan; Elizabeth M Krantz; Arthur Bagabag; Keith R Jerome
Journal:  J Clin Microbiol       Date:  2006-09-20       Impact factor: 5.948

3.  Comparison and application of a novel genotyping method, semiautomated primer-specific and mispair extension analysis, and four other genotyping assays for detection of hepatitis C virus mixed-genotype infections.

Authors:  Y W Hu; E Balaskas; M Furione; P H Yen; G Kessler; V Scalia; L Chui; G Sher
Journal:  J Clin Microbiol       Date:  2000-08       Impact factor: 5.948

4.  Evaluation of a new assay in comparison with reverse hybridization and sequencing methods for hepatitis C virus genotyping targeting both 5' noncoding and nonstructural 5b genomic regions.

Authors:  Elisa Martró; Victoria González; Andrew J Buckton; Verónica Saludes; Gema Fernández; Lurdes Matas; Ramón Planas; Vicenç Ausina
Journal:  J Clin Microbiol       Date:  2007-11-07       Impact factor: 5.948

5.  Hepatitis C virus (HCV) genotypes in the Caribbean island of Martinique: evidence for a large radiation of HCV-2 and for a recent introduction from Europe of HCV-4.

Authors:  Jenny Martial; Yoann Morice; Sylvie Abel; André Cabié; Christelle Rat; Frédéric Lombard; André Edouard; Serge Pierre-Louis; Philippe Garsaud; Odile Béra; Roger Chout; Emmanuel Gordien; Paul Deny; Raymond Césaire
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

6.  A natural intergenotypic recombinant of hepatitis C virus identified in St. Petersburg.

Authors:  Olga Kalinina; Helene Norder; Sergey Mukomolov; Lars O Magnius
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

7.  Identifying and quantifying genotypes in polyclonal infections due to single species.

Authors:  James M Colborn; Ousmane A Koita; Ousmane Cissé; Mamadou W Bagayoko; Edward J Guthrie; Donald J Krogstad
Journal:  Emerg Infect Dis       Date:  2006-03       Impact factor: 6.883

8.  The phylogenetic analysis of hepatitis C virus isolates obtained from two Iranian carriers revealed evidence for a new subtype of HCV genotype 3.

Authors:  Safieh Amini; Malek-Hossein Ahmadi Pour; Kayhan Azadmanesh
Journal:  Virus Genes       Date:  2006-12       Impact factor: 2.332

9.  Molecular incidence and clearance of Plasmodium falciparum infection.

Authors:  Donald J Krogstad; Ousmane A Koita; Mouctar Diallo; John L Gerone; Belco Poudiougou; Mahamadou Diakité; Yéya T Touré
Journal:  Malar J       Date:  2015-10-22       Impact factor: 2.979

10.  Dynamic of Mixed HCV Infection in Plasma and PBMC of HIV/HCV Patients Under Treatment With Peg-IFN/Ribavirin.

Authors:  Sabrina Bagaglio; Caterina Uberti-Foppa; Clelia Di Serio; Filippo Trentini; Andrea Andolina; Hamid Hasson; Emanuela Messina; Marco Merli; Lucy Porrino; Adriano Lazzarin; Giulia Morsica
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.